WaveMan · Form 4
Foehr Matthew W insider trades
> Search tickers & screens ⌘K
LIVE

Foehr Matthew W insider trades

Foehr Matthew W has filed 50 Form 4s with the SEC that we hold, for OmniAb, Inc. (OABI) (President and CEO, Director), Ligand Pharmaceuticals INC (LGND) (Reporting owner), Viking Therapeutics, Inc. (VKTX) (Director) and CIK 1893653 (CLO & Secretary, Director). Across all of them we count 12 purchases worth $8.1M and 12 sales worth $3.8M reported on Form 4. In the last 12 months: 0 purchases ($0) and 5 sales ($705.2K). The largest single trade was a sale of 11,160 shares of Ligand Pharmaceuticals INC worth $1.8M, dated 2021-11-11. The first filing on our record is dated 2021-08-05 and the latest 2026-04-07.

OmniAb, Inc. (OABI)

President and CEO, Director · 34 filings · 19 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-11-09P, purchase reported on Form 4100,000$276.0K2022-11-09
2022-11-30P, purchase reported on Form 4300,000$1.0M2022-12-01
2022-12-12P, purchase reported on Form 4150,000$565.5K2022-12-14
2023-05-12P, purchase reported on Form 4440,000$1.5M2023-05-15
2023-06-09P, purchase reported on Form 4115,000$519.8K2023-06-12
2023-08-14P, purchase reported on Form 445,000$246.6K2023-08-15
2023-11-10P, purchase reported on Form 495,000$405.6K2023-11-13
2023-12-12P, purchase reported on Form 4200,000$1.0M2023-12-13
2024-03-22P, purchase reported on Form 4225,000$1.2M2024-03-25
2024-05-24P, purchase reported on Form 4240,000$1.1M2024-05-28
2024-12-09S, sale reported on Form 413,634$56.3K2024-12-10
2025-01-21S, sale reported on Form 441,811$135.5K2025-01-22
2025-02-18S, sale reported on Form 413,964$51.4K2025-02-19
2025-02-19S, sale reported on Form 419,522$71.6K2025-02-19
2025-04-07S, sale reported on Form 419,382$38.8K2025-04-07
2025-12-08S, sale reported on Form 413,666$26.8K2025-12-09
2026-02-17S, sale reported on Form 420,754$35.3K2026-02-17
2026-02-18S, sale reported on Form 430,843$52.7K2026-02-18
2026-04-07S, sale reported on Form 419,244$28.7K2026-04-07

Ligand Pharmaceuticals INC (LGND)

Reporting owner · 8 filings · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-08-04S, sale reported on Form 48,840$969.5K2021-08-05
2021-11-11S, sale reported on Form 411,160$1.8M2021-11-12
2022-05-13P, purchase reported on Form 42,500$206.9K2022-05-13

Viking Therapeutics, Inc. (VKTX)

Director · 7 filings · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-05-02P, purchase reported on Form 445,000$111.2K2022-05-03
2026-01-02S, sale reported on Form 416,000$561.8K2026-01-05

CIK 1893653

CLO & Secretary, Director · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1237556) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms